Coerente Capital Management lowered its stake in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,443 shares of the software giant's stock after selling 7,941 shares during the quarter. Microsoft makes up approximately 10.2% of Coerente Capital Management's investment por...
Coerente Capital Management lowered its stake in Microsoft Corporation (NASDAQ:MSFT - Free Report) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,443 shares of the software giant's stock after selling 7,941 shares during the quarter. Microsoft makes up approximately 10.2% of Coerente Capital Management's investment portfolio, making the stock its 2nd largest position. Coerente Capital Management's holdings in Microsoft were worth $57,204,000 as of its most recent SEC filing. Other large investors have also recently bought and sold shares of the company. AlphaQuest LLC increased its holdings in Microsoft by 5.9% during the second quarter. AlphaQuest LLC now owns 342 shares of the software giant's stock worth $170,000 after buying an additional 19 shares during the last quarter. Seek First Inc. lifted its stake in Microsoft by 1.5% in the second quarter. Seek First Inc. now owns 1,358 shares of the software giant's stock valued at $675,000 after acquiring an additional 20 shares during the last quarter. Level Financial Advisors grew its position in shares of Microsoft by 0.8% in the 2nd quarter. Level Financial Advisors now owns 2,680 shares of the software giant's stock valued at $1,333,000 after acquiring an additional 20 shares during the period. Red Mountain Financial LLC increased its stake in shares of Microsoft by 0.7% during the 2nd quarter. Red Mountain Financial LLC now owns 2,761 shares of the software giant's stock worth $1,373,000 after purchasing an additional 20 shares during the last quarter. Finally, Onyx Financial Advisors LLC raised its holdings in shares of Microsoft by 0.3% in the 2nd quarter. Onyx Financial Advisors LLC now owns 7,108 shares of the software giant's stock valued at $3,536,000 after purchasing an additional 20 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds. Get Microsoft alerts: Sign Up Insider Transact...
E Fund Management Hong Kong Co. Ltd. raised its holdings in Apple Inc. (NASDAQ:AAPL - Free Report) by 774.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,659 shares of the iPhone maker's stock after acquiring an additional 21,840 shares during the period. Apple comprises 3.8% of E Fund Management ...
E Fund Management Hong Kong Co. Ltd. raised its holdings in Apple Inc. (NASDAQ:AAPL - Free Report) by 774.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,659 shares of the iPhone maker's stock after acquiring an additional 21,840 shares during the period. Apple comprises 3.8% of E Fund Management Hong Kong Co. Ltd.'s holdings, making the stock its 7th biggest holding. E Fund Management Hong Kong Co. Ltd.'s holdings in Apple were worth $6,279,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Financial Futures Ltd Liability Co. increased its stake in shares of Apple by 13.2% in the second quarter. Financial Futures Ltd Liability Co. now owns 3,552 shares of the iPhone maker's stock valued at $729,000 after buying an additional 415 shares during the period. Monarch Capital Management Inc. boosted its position in Apple by 4.6% during the 2nd quarter. Monarch Capital Management Inc. now owns 66,967 shares of the iPhone maker's stock worth $13,740,000 after buying an additional 2,920 shares during the period. American National Bank & Trust grew its holdings in Apple by 2.4% during the 2nd quarter. American National Bank & Trust now owns 195,482 shares of the iPhone maker's stock worth $40,107,000 after acquiring an additional 4,543 shares during the last quarter. Riverwater Partners LLC increased its position in Apple by 17.9% in the 2nd quarter. Riverwater Partners LLC now owns 5,404 shares of the iPhone maker's stock valued at $1,109,000 after acquiring an additional 819 shares during the period. Finally, Highland Capital Management LLC raised its stake in shares of Apple by 2.2% during the third quarter. Highland Capital Management LLC now owns 397,834 shares of the iPhone maker's stock valued at $101,301,000 after acquiring an additional 8,446 shares during t...
Galvin Gaustad & Stein LLC trimmed its position in shares of Apple Inc. (NASDAQ:AAPL - Free Report) by 6.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 100,239 shares of the iPhone maker's stock after selling 6,601 shares during the period. Apple makes up approximately 2.1% of Galvin Gaustad & Stein L...
Galvin Gaustad & Stein LLC trimmed its position in shares of Apple Inc. (NASDAQ:AAPL - Free Report) by 6.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 100,239 shares of the iPhone maker's stock after selling 6,601 shares during the period. Apple makes up approximately 2.1% of Galvin Gaustad & Stein LLC's investment portfolio, making the stock its 11th largest position. Galvin Gaustad & Stein LLC's holdings in Apple were worth $25,524,000 at the end of the most recent reporting period. Several other hedge funds have also recently bought and sold shares of the company. ROSS JOHNSON & Associates LLC raised its position in Apple by 1,800.0% during the first quarter. ROSS JOHNSON & Associates LLC now owns 190 shares of the iPhone maker's stock valued at $42,000 after purchasing an additional 180 shares in the last quarter. Nexus Investment Management ULC increased its stake in shares of Apple by 333.3% in the 2nd quarter. Nexus Investment Management ULC now owns 260 shares of the iPhone maker's stock valued at $53,000 after purchasing an additional 200 shares during the last quarter. LSV Asset Management acquired a new position in shares of Apple during the 4th quarter worth $65,000. Morgan Dempsey Capital Management LLC raised its holdings in shares of Apple by 41.0% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 430 shares of the iPhone maker's stock worth $88,000 after buying an additional 125 shares in the last quarter. Finally, HFM Investment Advisors LLC bought a new stake in shares of Apple during the 1st quarter worth $99,000. 67.73% of the stock is owned by institutional investors. Get Apple alerts: Sign Up Apple Trading Up 3.0% Shares of NASDAQ AAPL opened at $255.41 on Tuesday. The firm has a 50 day moving average price of $269.21 and a two-hundred day moving average price of $250.65. The stock has a market cap of $3.75 trillion, a P/E rat...
Richard Drury/DigitalVision via Getty Images Introduction Dyne Therapeutics ( DYN ) is a clinical-stage biotech firm with a ~3B market cap and 2 key clinical programs. Its pipeline focused on genetically driven muscle diseases using its proprietary FORCE™ platform . This technology uses a transferrin receptor 1 (TfR1) binding antibody fragment (fab) to deliver therapeutic payloads (ASOs, PMOs, siR...
Richard Drury/DigitalVision via Getty Images Introduction Dyne Therapeutics ( DYN ) is a clinical-stage biotech firm with a ~3B market cap and 2 key clinical programs. Its pipeline focused on genetically driven muscle diseases using its proprietary FORCE™ platform . This technology uses a transferrin receptor 1 (TfR1) binding antibody fragment (fab) to deliver therapeutic payloads (ASOs, PMOs, siRNAs) directly into skeletal, cardiac, and smooth muscle, as well as the central nervous system (CNS). The recent acquisition of its close competitor Avidity Biosciences by Novartis is a good validation for the rather unproven field of antibody-ASO/PMO conjugates Dyne is known for, and its share price jumped ~40% on the news. However, in this article I will explain: 1. While its first key clinical-stage drug, DYNE-101 (Zeleciment basivarsen), for DM1 is looking promising, its DMD drug, DYNE-251 (Zeleciment rostudirsen), data is weaker compared to Avidity's on their intended biomarker expression levels on a numerical basis. However, Dyne's recent release of functional data was strong, increasing the chance for Dyne to secure accelerated approval for Dyne-101. 2. With Dyne's recent close of a 350M stock offering, it is in a comfortable financial position to go it alone if it needs to, which gives them more leverage for a potential buyout. Given its "twin" company Avidity was bought at 12B last year, it makes Dyne's current valuation of 2.75B quite undervalued in comparison. The Science Dyne Therapeutics is focused on treating genetically driven muscle diseases using its proprietary FORCE™ platform. This technology overcomes the historic delivery limitations of muscle therapeutics by using an antibody fragment that binds to the Transferrin Receptor 1 (TfR1)-which is highly expressed on muscle cells-to deliver therapeutic payloads (ASOs, PMOs, siRNAs) directly into skeletal, cardiac, and smooth muscle. The technology is similar to the famous antibody-drug conjugate (ADC) field, ...
(1st row from L to R): Australia's Prime Minister Anthony Albanese, Brazil's President Luiz Inacio Lula da Silva, South Africa's President Cyril Ramaphosa, President of Angola and Chairperson of the African Union Joao Lourenco and Canada's Prime Minister Mark Carney react as they attend a family photo event during a G20 Leaders' Summit plenary session at the Nasrec Expo Centre in Johannesburg on N...
(1st row from L to R): Australia's Prime Minister Anthony Albanese, Brazil's President Luiz Inacio Lula da Silva, South Africa's President Cyril Ramaphosa, President of Angola and Chairperson of the African Union Joao Lourenco and Canada's Prime Minister Mark Carney react as they attend a family photo event during a G20 Leaders' Summit plenary session at the Nasrec Expo Centre in Johannesburg on November 22, 2025. Gianluigi Guercia | Afp | Getty Images With the resurgence of U.S. dominance in the West and the apparent ripping up of the rules-based international order, some are looking to the world's "middle powers" as a possible bulwark against increasing unilateralism among global superpowers. Canada's Prime Minister Mark Carney lent his voice to this hope last week, telling delegates at the World Economic Forum (WEF) that "middle powers" must work together to counter the rise of hard power, the disintegration of multilateral institutions like the United Nations and World Trade Organization, and to build a more cooperative and peaceful world. "Great powers can afford, for now, to go it alone. They have the market size, the military capacity and the leverage to dictate terms. Middle powers do not," Carney told delegates. "The middle powers must act together, because if we're not at the table, we're on the menu," he warned. Superpowers have often defined as countries with a permanent seat on the United Nations Security Council, like China, France, Russia, the U.K. and the U.S. However, the world's only current superpowers of any real consequence are arguably China and the U.S. The definition of "middle powers" is more opaque, although it's generally used to refer to states that have economic, diplomatic or political clout but are seen to be in the "second-tier" of the geopolitical hierarchy. Leaders pose for a family photo on the opening day of the G20 Leaders' Summit at the Nasrec Expo Centre in Johannesburg, South Africa, on Nov. 22, 2025. Misper Apawu | Via Reuter...
( January 27, 2026, 09:07 GMT | Official Statement) -- MLex Summary: US chipmaker Micron Technology has broken ground on a $24 billion 10-year advanced wafer fabrication facility within the company's existing NAND manufacturing complex in Singapore. In a statement, Micron said production is scheduled to start in the second half of 2028, with the chipmaking facility designed to meet growing AI-driv...
( January 27, 2026, 09:07 GMT | Official Statement) -- MLex Summary: US chipmaker Micron Technology has broken ground on a $24 billion 10-year advanced wafer fabrication facility within the company's existing NAND manufacturing complex in Singapore. In a statement, Micron said production is scheduled to start in the second half of 2028, with the chipmaking facility designed to meet growing AI-driven demand for NAND memory. The project will create 1,600 jobs and use advanced robotics, smart manufacturing and co-located research to support AI applications, strengthen supply chain resilience and reinforce Singapore’s role in the global semiconductor ecosystem, Micron said.The statement follows.... Prepare for tomorrow’s regulatory change, today MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term. Know what others in the room don’t, with features including: Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific Curated case files bringing together news, analysis and source documents in a single timeline Experience MLex today with a 14-day free trial.
India and the EU have finalised a landmark free trade agreement, which European Commission president Ursula von der Leyen hailed as the “mother of all deals”. The agreement comes after almost two decades of on-off negotiations between India and the EU, which vastly accelerated in the past six months and were finally concluded late on Monday night. The deal is expected to open up India’s vast and t...
India and the EU have finalised a landmark free trade agreement, which European Commission president Ursula von der Leyen hailed as the “mother of all deals”. The agreement comes after almost two decades of on-off negotiations between India and the EU, which vastly accelerated in the past six months and were finally concluded late on Monday night. The deal is expected to open up India’s vast and traditionally tightly guarded market to the 27 nations in the bloc, with a focus on manufacturing and the services sector. It is expected to ease market access for key European products, including cars and wine, in return for easier exports of textiles, gems and pharmaceuticals. The agreement is expected to double EU exports to India by 2032 by eliminating or cutting tariffs in 96.6% of traded goods by value, and will lead to savings of €4bn (£3.5bn) in duties for European companies, the EU said. “Europe and India are making history today,” von der Leyen said in a statement after landing in Delhi, where she met with the Indian prime minister, Narendra Modi, on Tuesday. “We have concluded the mother of all deals. We have created a free trade zone of two billion people, with both sides set to benefit.” Von der Leyen had previously stated that she expected exports to India to double after the deal, with the EU granted unprecedented access to the previously heavily protected Indian market. India, the world’s largest country with a population of 1.4 billion, is also one of the world’s fastest-growing economies and is on track to become its fourth-largest economy this year, according to International Monetary Fund. The deal is one of the most comprehensive that India has ever signed and Modi emphasised that it represented about a third of global trade, calling it the “biggest free trade deal in history”. “This agreement has brought massive opportunities for 1.4 billion Indians and millions of people in European countries,” he said. “It has become a wonderful example of synergy bet...
The shares of UnitedHealth, Humana and other health insurers were clobbered on Tuesday after a preliminary payment proposal for Medicare Advantage fell way short of analyst expectations.
The shares of UnitedHealth, Humana and other health insurers were clobbered on Tuesday after a preliminary payment proposal for Medicare Advantage fell way short of analyst expectations.
For the better part of the last seven years, Wall Street has been a stomping ground for wealth creation . The benchmark S&P 500 has rallied by at least 16% in six of the last seven years, with the 2022 bear market being the lone exception. Investors have had plenty to be excited about, including the evolution of artificial intelligence (AI), the advent of quantum computing, the prospect of lower i...
For the better part of the last seven years, Wall Street has been a stomping ground for wealth creation . The benchmark S&P 500 has rallied by at least 16% in six of the last seven years, with the 2022 bear market being the lone exception. Investors have had plenty to be excited about, including the evolution of artificial intelligence (AI), the advent of quantum computing, the prospect of lower interest rates, record-breaking share buyback activity by S&P 500 companies, and a resilient U.S. economy. Billionaire money managers have taken notice of these catalysts, with many holding a stake in one or more of America's most influential public companies. We know this because institutional investors with at least $100 million in assets under management are required to file Form 13F with the Securities and Exchange Commission no later than 45 calendar days after the end of each quarter. A 13F details for investors the stocks that Wall Street's savviest fund managers bought and sold in the latest quarter. Continue reading